Hemorrhoids Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Double Blind Study on the Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade Hemorrhoids.
Condition:   Hemorrhoids Interventions:   Drug: Monad 1;   Drug: Monad 2;   Drug: Monad 3;   Drug: Combination - CITI-002 (low dose);   Drug: Combination - CITI-002 (high dose) Sponsors:   Citius Pharmaceuticals, Inc.;   Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2022 Category: Research Source Type: clinical trials